Novagali Pharma SA
http://www.novagali.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Novagali Pharma SA
Appointments: Piramal Pharma, Oxeia, Artios Eyevensys and Bone Therapeutics
This week's roundup includes a new CEO for Oxeia, in addition to various other high-level appointments by Piramal Pharma Solutions, Bone Therapeutics, Kiadis and biOasis. Artios Pharma also welcomes AstraZeneca's former senior director bioscience, oncology to its team.
Financings Of The Fortnight: Idenix To Forge Ahead On HCV Combo After Novartis’ Departure
Plus news on recent financial activity by Mersana Therapeutics, Hyperion Therapeutics, Atterocor and Exelixis.
Financings Of The Fortnight: Secondary Offerings Up From Pace Set In 2010 And 2011
Plus news on recent financings by Genkyotex, Synageva, Nektar Therapeutics and Edmond de Rothschild Investment Partners.
EdRIP raising €200M for new life sciences VC fund
Four years after closing the BioDiscovery 3 at €156 million, Edmond de Rothschild Investment Partners is now on the road raising a €200 million fourth fund to invest innovative European life sciences companies. The French venture capitalist started fundraising three weeks ago and is confident that it will be able to complete a first closing at more than €100 million by the end of April or early May.